Lipoprotein(a) and residual risk during statin therapy: Thresholds guide decisions, but risk is continuous

Clicks: 21
ID: 330697
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #151 of 288 articles by views in european journal of preventive cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 288 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Mohammed Ammar, MD, MSc, MMSc, Samia Mora, MD, MHS; Lipoprotein(a) and residual risk during statin therapy: Thresholds guide decisions, but risk is continu
Reference Key
openalex_W7214945019 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal european journal of preventive cardiology
Year 2026
DOI
10.1093/eurjpc/zwag502
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.